GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
about
Hepatocellular carcinoma: Review of disease and tumor biomarkersNanodiamonds: The intersection of nanotechnology, drug development, and personalized medicineCancer Microenvironment and Endoplasmic Reticulum Stress ResponseNanoparticle-based targeted therapeutics in head-and-neck cancerCrystal structure of the human glucose transporter GLUT1Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospectsCyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomasDNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinomaTetravalent antibody-scTRAIL fusion proteins with improved properties.Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.(18)F-FDG-PET/CT predicts the distribution of microsatellite lesions in hepatocellular carcinoma.Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.Characterization of monocarboxylate transporter activity in hepatocellular carcinomaBioactive food components and cancer-specific metabonomic profiles.Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.Expression and function of methylthioadenosine phosphorylase in chronic liver disease.Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers.Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHATumor cell metabolism: an integral view.PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinomaDeregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric CancerCombination treatment with hypoxia-activated prodrug evofosfamide (TH-302) and mTOR inhibitors results in enhanced antitumor efficacy in preclinical renal cell carcinoma models.The applications of corrected standardized uptake values in the diagnosis of peripheral lung lesions.GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular CarcinomaDesigning polymers with sugar-based advantages for bioactive delivery applicationsGlucose transporter isoform 1 expression enhances metastasis of malignant melanoma cellsActivating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Glucose conjugation for the specific targeting and treatment of cancer.miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.GLUT1 as a therapeutic target in hepatocellular carcinoma.Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients.
P2860
Q26750796-7F015142-5F5F-4CA4-9DDB-33CDA888CAA0Q26776095-8D8726DB-3CC0-4D05-A6E2-EDDAC6DEAFBEQ26778533-83A6A320-DD69-48BB-AD15-8CCDE96F1D40Q26999699-B27C9188-C074-4502-9D4A-8258BC599E89Q27690274-CAC8453D-7823-4522-9C0A-38C263926506Q28076454-1421401F-BE50-419F-A087-5D6FA493AE2BQ28293433-EB6C4E89-000A-4278-8035-8587BA4F5A81Q28383720-1AE6A71A-326F-496C-9524-DFC7934038C1Q33619046-0A8FEC33-A1D4-4F8A-8AAA-52215368DCEBQ33681427-B8900D28-99C1-494E-BFC7-E33E4B7CF005Q33760940-80F76A6C-899F-4EDD-BBB5-BD2ABD56F9D9Q33933065-9B741289-3506-4AC9-B745-991DCCE93979Q33986152-C6E0AF83-7345-4A62-9948-728ACBD62F56Q34137358-DFBD8099-5126-4193-892B-7554F862FA21Q34338757-2AC964B5-361B-4DB3-B9B3-9F8188D24D75Q34756307-412112D8-69B8-400F-9A2B-38B2D83DB6CDQ34972287-C6B0901C-BED6-4E40-A827-D9703A7D80D2Q35063777-D43B9C3D-C5C3-4080-895E-818D0A1E2B62Q35536490-C976E325-AE58-4D3A-8645-623EE13F06CBQ35657827-25FC4E79-6ABE-4FB6-B8FF-32D8A2549864Q35674921-490D874C-6853-4376-881C-1C9FCE7BC6ADQ35760954-BC443867-0C1F-4DE3-BF85-523B26233D36Q35793653-A7DB10F0-7F9C-4A75-B809-EBCB152F6473Q35902612-C55D6FEB-B637-4964-9E7A-387A115B89EAQ35993104-C404625A-EC35-4500-9AE5-34943D4D9EB6Q36152297-666D52A4-5BDA-472B-BFBA-6A7FDDE22EC5Q36236396-6B4C64CF-F89E-4A6E-BAF9-B21EDF73B2CEQ36307576-34572AE4-BA26-4E28-92D3-D40F708074C6Q36544964-D3C308F4-5FEC-4FE4-8980-662E9323C2B2Q36557906-1EA2EB6E-1287-4EFF-887A-E8BB30D1B175Q36657326-99AD022F-05E0-4831-92D2-8AFF064DC5D5Q36658938-61403E05-B4E6-47CA-A0D3-9B9E951ED5F1Q36687966-65857683-E06C-4775-A694-6624193233B7Q36729549-6C93C948-7310-481E-9B7A-389510C67B6DQ37031827-FD2723BD-26A8-4605-B743-AC822480FAE6Q37121662-AC3BDE87-1354-4923-B8C2-1CC1CB9C3BD3Q37200539-9F8DC258-FFC9-4957-9053-0A4DA5DB567DQ37376524-0A6C7011-D3E7-46C9-A547-554C1DECBE30Q37623840-7C5C7E3E-F300-4115-8B8D-72B809BF2192Q37746128-C02C0D42-FCD1-4E7C-BBE8-10E30C304F23
P2860
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@en
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@nl
type
label
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@en
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@nl
prefLabel
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@en
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@nl
P2093
P2860
P50
P1476
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
@en
P2093
Abbas Agaimy
Arndt Hartmann
Christina Warnecke
Claus Hellerbrand
Jörg Marienhagen
Marina Kreutz
Oliver Stoeltzing
Peter J Oefner
Thomas Amann
Ulrike Maegdefrau
P2860
P304
P356
10.2353/AJPATH.2009.080596
P407
P577
2009-03-12T00:00:00Z